New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.

Details

Language :

English

ISSN :

25729241

Volume :

8

Issue :

4

Database :

Complementary Index

Journal :

HemaSphere

Publication Type :

Academic Journal

Accession number :

178066838

Full Text :

https://doi.org/10.1002/hem3.70